BSE filing, NSE: NEULANDLAB. Summary written from the filing by ALFA Finder's alert engine.
Neuland Laboratories Ltd: key numbers
- Share price
- ₹19,250.00
- Market cap
- ₹24,698 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹364.0 Cr
- P/E (TTM)
- 49.6×Sector 46.1×
- Promoter holding
- 32.26%-0.36% QoQ
- FII holding
- 21.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neuland Laboratories Ltd
All →Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.
Neuland Laboratories Business Update
Neuland Laboratories' Unit 3 manufacturing facility received an Establishment Inspection Report from the US FDA. The agency has officially closed the inspection.
Neuland Laboratories Other Announcement
Neuland Laboratories Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Neuland Laboratories Promoter Selling (Off-Market)
Neuland Laboratories' promoter group, Davuluri Rohini Niveditha Rao and Davuluri Saharsh Rao, completed an off-market inter-se transfer of 10,000 shares via gift.
- Promoter stake change
- +0.07%
Neuland Laboratories Production Started
Neuland commissioned its first commercial peptide manufacturing module with 7,000L reactor capacity. Module two expansion is underway to meet rising customer demand for peptide APIs.
- peptide manufacturing reactor capacity
- 7000 L
Neuland Laboratories Capacity Expansion: ₹126 Cr Investment
Neuland Laboratories' board approved ₹126 Crore capex to acquire 134 acres of land in Andhra Pradesh for future expansion. The company holds ROFR on additional land.
- Value
- ₹126.0 Cr
- land acquisition
- 134.0 acres
Other board meeting date announcements
All →Ampvolts Board Meeting Date
Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.
Kasturi Metal Composite Board Meeting Date
Kasturi Metal Composite scheduled a board meeting for November 3, 2026, to approve H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Ester Industries Board Meeting Date
Ester Industries informs that its Board will meet on 3 Nov 2026 to approve un-audited Q2/H1 results. No financial figures or other decisions are announced at this stage.
Action Construction Equipment Board Meeting Date
Action Construction Equipment scheduled its board meeting for November 12, 2026 to approve Q1 and H1 FY27 unaudited results. No material decision has been taken yet.
Valiant Communications Board Meeting Date
Valiant Communications intimated that its Board will meet on 05-11-2026, inter alia to consider the Q1 FY27 unaudited results. The trading window stays closed until 48 hours after the results are announced.
Hannah Joseph Hospital Board Meeting Date
Hannah Joseph Hospital Ltd intimated a Board meeting on 05/11/2026 to approve H1 FY27 unaudited results. The trading window has been closed pending that announcement.